246 related articles for article (PubMed ID: 18646229)
1. Process considerations related to the microencapsulation of plasmid DNA via ultrasonic atomization.
Ho J; Wang H; Forde GM
Biotechnol Bioeng; 2008 Sep; 101(1):172-81. PubMed ID: 18646229
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination.
Ho J; Huang Y; Danquah MK; Wang H; Forde GM
Eur J Pharm Sci; 2010 Mar; 39(5):412-20. PubMed ID: 20117207
[TBL] [Abstract][Full Text] [Related]
3. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing hepatitis B surface antigen and Interleukin-2.
Eratalay A; Coşkun-Ari FF; Oner F; Ozcengīz E
J Microencapsul; 2010; 27(1):48-56. PubMed ID: 19545223
[TBL] [Abstract][Full Text] [Related]
5. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
Hsu YY; Hao T; Hedley ML
J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
[TBL] [Abstract][Full Text] [Related]
6. Formulation and in vitro transfection efficiency of poly (D, L-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery.
Gebrekidan S; Woo BH; DeLuca PP
AAPS PharmSciTech; 2000 Oct; 1(4):E28. PubMed ID: 14727893
[TBL] [Abstract][Full Text] [Related]
7. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
9. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticles.
Tse MT; Blatchford C; Oya Alpar H
Int J Pharm; 2009 Mar; 370(1-2):33-40. PubMed ID: 19059325
[TBL] [Abstract][Full Text] [Related]
11. Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres.
Zhao K; Li GX; Jin YY; Wei HX; Sun QS; Huang TT; Wang YF; Tong GZ
J Microencapsul; 2010; 27(2):178-86. PubMed ID: 20121488
[TBL] [Abstract][Full Text] [Related]
12. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.
Intra J; Salem AK
J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752
[TBL] [Abstract][Full Text] [Related]
13. Controlled and sustained gene delivery from injectable, porous PLGA scaffolds.
Jeon O; Krebs M; Alsberg E
J Biomed Mater Res A; 2011 Jul; 98(1):72-9. PubMed ID: 21538827
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods.
Atuah KN; Walter E; Merkle HP; Alpar HO
J Microencapsul; 2003; 20(3):387-99. PubMed ID: 12881118
[TBL] [Abstract][Full Text] [Related]
16. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
Della Porta G; Reverchon E
Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
[TBL] [Abstract][Full Text] [Related]
17. Morphology and release kinetics of technetium-99m(V) dimercaptosuccinic acid loaded, poly(lactic-co-glycolic)acid microspheric delivery system. An experimental approach that may be used for targeted radiation treatment.
Shukla J; Bandopadhyaya GP; Varma IK; Kumar R; Maulik SK
Hell J Nucl Med; 2007; 10(1):9-13. PubMed ID: 17450243
[TBL] [Abstract][Full Text] [Related]
18. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes.
Aral C; Akbuga J
J Pharm Pharm Sci; 2003; 6(3):321-6. PubMed ID: 14738712
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery.
Son S; Kim WJ
Biomaterials; 2010 Jan; 31(1):133-43. PubMed ID: 19783041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
